Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders L Carlson

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Diabetes and Its Complications|March 13, 2022
Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchangeKara Mizokami-Stout, Ryan Bailey, Lynn Ang, et al.
Journal of Diabetes Science and Technology|December 16, 2022
Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility CriteriaRodolfo J Galindo, Grazia Aleppo, Christopher G Parkin, et al.
Obesity (Silver Spring, Md.)|June 27, 2023
BMI, insulin sensitivity, and cognition in early type 2 diabetes: The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness StudyJosé A Luchsinger, Erin J Kazemi, Danurys L Sanchez, et al.
Journal of Diabetes Science and Technology|March 5, 2024
Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ TrialAnders L Carlson, Timothy E Graham, Halis K Akturk, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2025
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021Janna Manjelievskaia, Viral N Shah, Anders L Carlson, et al.
Diabetes Technology & Therapeutics|February 6, 2025
Safety and Effectiveness of MiniMed<sup>TM</sup> 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 DiabetesAnuj Bhargava, Richard M Bergenstal, Mark L Warren, et al.
Journal of Diabetes Science and Technology|December 24, 2019
Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM StudyAnders L Carlson, Lauren G Kanapka, Kellee M Miller, et al.
Diabetes Care|February 25, 2025
Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)Kristina M Utzschneider, Mark Tripputi, Nicole M Butera, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Diabetes Technology & Therapeutics|May 17, 2024
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin PensGregg D Simonson, Amy B Criego, Tadej Battelino, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Diabetes and Its Complications|March 13, 2022
Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchangeKara Mizokami-Stout, Ryan Bailey, Lynn Ang, et al.
Journal of Diabetes Science and Technology|December 16, 2022
Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility CriteriaRodolfo J Galindo, Grazia Aleppo, Christopher G Parkin, et al.
Obesity (Silver Spring, Md.)|June 27, 2023
BMI, insulin sensitivity, and cognition in early type 2 diabetes: The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness StudyJosé A Luchsinger, Erin J Kazemi, Danurys L Sanchez, et al.
Journal of Diabetes Science and Technology|March 5, 2024
Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ TrialAnders L Carlson, Timothy E Graham, Halis K Akturk, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2025
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021Janna Manjelievskaia, Viral N Shah, Anders L Carlson, et al.
Diabetes Technology & Therapeutics|February 6, 2025
Safety and Effectiveness of MiniMed<sup>TM</sup> 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 DiabetesAnuj Bhargava, Richard M Bergenstal, Mark L Warren, et al.
Journal of Diabetes Science and Technology|December 24, 2019
Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM StudyAnders L Carlson, Lauren G Kanapka, Kellee M Miller, et al.
Diabetes Care|February 25, 2025
Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)Kristina M Utzschneider, Mark Tripputi, Nicole M Butera, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Diabetes Technology & Therapeutics|May 17, 2024
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin PensGregg D Simonson, Amy B Criego, Tadej Battelino, et al.
Pageof 6